Susquehanna International Group’s Onconova Therapeutics, Inc. Warrants ONTXW Stock Holding History

Susquehanna International Group’s Portfolio ONTXW Stock Details ONTXW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-58,674	Closed	-$6K	–	13157
2020 Q4	$6K	Buy	58,674 +47,998	+450%	+$2.97K	﹤0.01%	10931
2020 Q3	$1K	Sell	10,676 -13,506	-56%	-$1.21K	﹤0.01%	10461
2020 Q2	$2K	Buy	+24,182	New	+$2.02K	﹤0.01%	10017
2020 Q1	–	Sell	-42,467	Closed	-$2K	–	11184
2019 Q4	$2K	Sell	42,467 -46,154	-52%	-$1.08K	﹤0.01%	9592
2019 Q3	$2K	Buy	88,621 +450	+0.5%	+$32	﹤0.01%	10063
2019 Q2	$16K	Hold	88,171	–	–	﹤0.01%	10032
2019 Q1	$5K	Buy	+88,171	New	+$11.2K	﹤0.01%	8678
2018 Q1	–	Sell	-173,112	Closed	-$61K	–	10535
2017 Q4	$61K	Hold	173,112	–	–	﹤0.01%	8858
2017 Q3	$68K	Hold	173,112	–	–	﹤0.01%	8468
2017 Q2	$78K	Hold	173,112	–	–	﹤0.01%	8789
2017 Q1	$145K	Hold	173,112	–	–	﹤0.01%	8224
2016 Q4	$107K	Buy	+173,112	New	+$155K	﹤0.01%	9051

Other funds holding ONTXW

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TSS

Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

Susquehanna International Group's ONTXW Position: Q1 2021 in Review

Susquehanna International Group sold out of Onconova Therapeutics, Inc. Warrants (ONTXW) in Q1 2021, closing a stake of 58,674 shares — an estimated $6K sold.

Susquehanna International Group first reported a position in ONTXW in Q4 2016 and held it in 12 quarters. The position peaked at $145K in Q1 2017. 2 funds tracked by Wall St. Rank hold ONTXW as of Q1 2021.

Susquehanna International Group reported no remaining Onconova Therapeutics, Inc. Warrants position as of Q1 2021 after selling out during the quarter.
Susquehanna International Group sold 58,674 Onconova Therapeutics, Inc. Warrants shares in Q1 2021, an estimated $6K.
Susquehanna International Group first reported a position in Onconova Therapeutics, Inc. Warrants in Q4 2016 and held it in 12 quarters.
Susquehanna International Group's Onconova Therapeutics, Inc. Warrants position peaked at $145K in Q1 2017.
2 funds tracked by Wall St. Rank held Onconova Therapeutics, Inc. Warrants as of Q1 2021.

Based on Susquehanna International Group's 13F filing for Q1 2021, filed 17 May 2021.